Abstract
Acetylcholinesterase (AChE) inhibitors are an important class of medicinal agents useful for the treatment of Alzheimer ’ s disease, glaucoma, myasthenia gravis and for the recovery of neuromuscular block in surgery. To rationalize the structural requirements of AChE inhibitors we attempt to derive a coherent AChE-inhibitor recognition pattern based on literature data of molecular modelling and quantitative structure-activity relationship (QSAR) analyses. These data are summarised from nearly all therapeutically important chemical classes of reversible AChE inhibitors, e.g., derivatives of physostigmine, tacrine, donepezil and huperzine A. Interactions observed from X-ray crystallography between these inhibitors and AChE have also been incorporated and compared with modelling and QSAR results. It is concluded that hydrophobicity and the presence of an ionizable nitrogen are the pre-requisites for the inhibitors to interact with AChE. However the mode of interaction i.e., the 3-dimensional (3D) positioning of the inhibitor in the active site of the enzyme varies among different chemical classes. It is also recognised that water molecules play crucial roles in defining these different 3D positioning. The information on AChE-inhibitor interactions provided should be useful for future discovery of new chemical classes of AChE inhibitors, especially from De Novo design and hybrid construction.
Keywords: molecular modelling, QSAR, revesibile acetylcholines terase inhibitors, acetylcholinesterase AChE inhibitors, medicinal agents, alzheimer s disease, glaucoma, myasthenia gravis, quantitative structure activity relationship, physostigmine, tacrine, donepezil, huperzine A, x ray crystallography, d dimensional 3D, interactions, De Novo design, calabar bean, neurotransmitter acetylcholine ACh, central nervous system CNS, molecular interactions, torpedo californica, electrophorus electricus, 9 amino 1 2 3 4 tetraydroacridin 1 ol analogues, benzylamines, morpholinoalkylcarbamoyloxyeseroline analogues, heptylphysostigmine, benzylpiperdines, huperzine A analogues
Current Medicinal Chemistry
Title: Molecular Modelling and QSAR of Reversible Acetylcholines-terase Inhibitors
Volume: 7 Issue: 3
Author(s): J. Kaur and M. -Q. Zhang
Affiliation:
Keywords: molecular modelling, QSAR, revesibile acetylcholines terase inhibitors, acetylcholinesterase AChE inhibitors, medicinal agents, alzheimer s disease, glaucoma, myasthenia gravis, quantitative structure activity relationship, physostigmine, tacrine, donepezil, huperzine A, x ray crystallography, d dimensional 3D, interactions, De Novo design, calabar bean, neurotransmitter acetylcholine ACh, central nervous system CNS, molecular interactions, torpedo californica, electrophorus electricus, 9 amino 1 2 3 4 tetraydroacridin 1 ol analogues, benzylamines, morpholinoalkylcarbamoyloxyeseroline analogues, heptylphysostigmine, benzylpiperdines, huperzine A analogues
Abstract: Acetylcholinesterase (AChE) inhibitors are an important class of medicinal agents useful for the treatment of Alzheimer ’ s disease, glaucoma, myasthenia gravis and for the recovery of neuromuscular block in surgery. To rationalize the structural requirements of AChE inhibitors we attempt to derive a coherent AChE-inhibitor recognition pattern based on literature data of molecular modelling and quantitative structure-activity relationship (QSAR) analyses. These data are summarised from nearly all therapeutically important chemical classes of reversible AChE inhibitors, e.g., derivatives of physostigmine, tacrine, donepezil and huperzine A. Interactions observed from X-ray crystallography between these inhibitors and AChE have also been incorporated and compared with modelling and QSAR results. It is concluded that hydrophobicity and the presence of an ionizable nitrogen are the pre-requisites for the inhibitors to interact with AChE. However the mode of interaction i.e., the 3-dimensional (3D) positioning of the inhibitor in the active site of the enzyme varies among different chemical classes. It is also recognised that water molecules play crucial roles in defining these different 3D positioning. The information on AChE-inhibitor interactions provided should be useful for future discovery of new chemical classes of AChE inhibitors, especially from De Novo design and hybrid construction.
Export Options
About this article
Cite this article as:
Kaur J. and Zhang -Q. M., Molecular Modelling and QSAR of Reversible Acetylcholines-terase Inhibitors, Current Medicinal Chemistry 2000; 7 (3) . https://dx.doi.org/10.2174/0929867003375254
DOI https://dx.doi.org/10.2174/0929867003375254 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Selective Agents for Serotonin2C (5-HT2C) Receptor
Current Topics in Medicinal Chemistry Potential Role of Neuroimaging Markers for Early Diagnosis of Dementia in Primary Care
Current Alzheimer Research Patent Review
Combinatorial Chemistry & High Throughput Screening A SELDI-TOF-MS Study in Lacunar Stroke with Subsequent Haptoglobin Phenotyping
Current Neurovascular Research The Intriguing Occurrence of Segmental Arterial Mediolysis: Case Report and Concise Literature Review
Cardiovascular & Hematological Disorders-Drug Targets Recent Patents on Perovskite Ferroelectric Nanostructures
Recent Patents on Nanotechnology Aquaporin Biology and Nervous System
Current Neuropharmacology Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Mitochondrial Disturbances, Tryptophan Metabolites and Neurodegeneration: Medicinal Chemistry Aspects
Current Medicinal Chemistry Opiate Drug Use and the Pathophysiology of NeuroAIDS
Current HIV Research Vasoactive Compounds in the Neonatal Period
Current Medicinal Chemistry Connecting the Brain and New Drug Targets for Schizophrenia
Current Pharmaceutical Design Transition Metal Based Anticancer Drugs
Current Topics in Medicinal Chemistry Synthesis and Biological Activities of Sulfinyl Acetamide Derivatives for Narcolepsy Treatment
Letters in Drug Design & Discovery Mechanisms of Adipocytokine-Mediated Trastuzumab Resistance in HER2-Positive Breast Cancer Cell Lines
Current Pharmacogenomics and Personalized Medicine Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry Fiber Diffraction As a Screen for Amyloid Inhibitors
Current Alzheimer Research Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson’s Disease
CNS & Neurological Disorders - Drug Targets Correlation of Alzheimer-like Tau Hyperphosphorylation and fMRI Bold Intensity
Current Alzheimer Research Bivalent Ligands Derived from Huperzine A as Acetylcholinesterase Inhibitors
Current Topics in Medicinal Chemistry